Cita APA

Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.

Citación estilo Chicago

Horton, C., TJ Davies, P. Lahiri, P. Sachamitr, and PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.

Cita MLA

Horton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.